M&A Rewind: Watson Pharma To Give DETAILS, Pandora DRAMA
Watson Pharmaceuticals’ (NYSE:WPI) €4.25 billion ($5.6 billion) proposed purchase of the Swiss generic drug firm Actavis Group, has drawn a FTC request for further details. The former remains confident that the transaction will close in the fourth quarter.
Don’t Miss: Why is NBC Demanding This SPLIT?
A bit of false takeover drama on Thursday, as Pandora (NYSE:P) shares took off on chatter that the company might be acquired by Comcast (NASDAQ:CMCSA), even though such a merger of two entities with such distinct cultures didn’t quite sound right to industry observers. Pandora shares rose sharply but then fell back, when a source claimed that Comcast isn’t going to bid on the top Internet radio player.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.